Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 May 31;17(3):551–559.e1. doi: 10.1016/j.cgh.2018.05.039

Table 3.

Median overall survival in months, stratified by race/ethnicity

White (n=401) Black (n=384) Hispanic (n=332) Black vs. White (HR, 95%CI) Hispanic vs. White (HR, 95%CI)
Overall 16.3 (5.2 – 61.2) 10.6 (3.3 – 34.1) 14.4 (3.9 – 52.7) 1.34 (1.12 – 1.60) 1.08 (0.89 – 1.30)
BCLC stage A 45 (17.0 – 94.6) 28.4 (13.2 – 55.7) 42.6 (17.0 – 82.6) 1.4 (0.97 – 1.91) 0.93 (0.64 – 1.36)
BCLC stage B 14.8 (6.0 – 29.8) 16.8 (8.4 –27.8) 16.0 (7.9 – 22.0) 0.92 (0.59 – 1.42) 1.11 (0.72 – 1.72)
BCLC stage C 5.8 (1.8 – 10.3) 4.5 (2.0 – 7.9) 4.0 (2.2 – 7.9) 1.13 (0.83 – 1.55) 1.07 (0.75 – 1.52)
BCLC stage D 2.3 (1.2 – 13.6) 1.5 (0.7 – 3.1) 3.5 (1.1 – 8.5) 1.77 (1.19 – 2.62) 0.97 (0.66 – 1.43)

BCLC – Barcelona Clinic Liver Cancer

*

Interquartile ranges (IQR) reported for median survival time